CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
98.32
0.00 (0.00%)
At close: Jun 18, 2026, 4:00 PM EDT
98.35
+0.03 (0.03%)
Pre-market: Jun 22, 2026, 8:53 AM EDT

CVS Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
100,426105,693102,87198,91594,58897,71095,42891,23488,43793,81389,76488,92185,27883,84681,15980,63676,82676,60473,79472,616
Revenue Growth (YoY)
6.17%8.17%7.80%8.42%6.96%4.15%6.31%2.60%3.70%11.89%10.60%10.27%11.00%9.45%9.98%11.04%11.19%10.14%10.05%11.13%
Cost of Revenue
84,80292,12689,06585,32280,19284,81182,87077,85175,87679,93776,18775,31871,90369,98767,76666,78063,43262,88061,09259,421
Gross Profit
15,62413,56713,80613,59314,39612,89912,55813,38312,56113,87613,57713,60313,37513,85913,39313,85613,39413,72412,70213,195
Selling, General & Admin
10,94411,45511,28811,21211,02210,52110,55710,33810,29010,5039,8769,8739,58010,0899,6129,1879,32410,0209,2108,869
Other Operating Expenses
-05,725--101,169--011496-349872,740-4430431-
Total Operating Expenses
10,94411,45517,01311,21211,02210,53111,72610,33810,29010,5039,88710,3699,23110,17612,3529,1879,76710,0209,6418,869
Operating Income
4,6802,112-3,2072,3813,3742,3688323,0452,2713,3733,6903,2343,4463,659-3,9194,6693,5452,3463,0614,326
Interest Expense
-774-787-784763-785-758-752732716690693686589552566583586608602636
Other Non-Operating Income (Expense)
3229509-29282525-24-25-22-22-22-22-43-41-43-42-127-412-45
Total Non-Operating Income (Expense)
-742-758-275734-757-733-727708691668671664567509525540544481190591
Pretax Income
3,9381,354-3,4821,6472,6172,1261052,3371,5802,7053,0192,5702,8793,150-4,4444,1293,0011,6872,1453,735
Provision for Income Taxes
981-1,56950863483550334569456658754656737818-1,0451,090646300558944
Net Income
2,9572,923-3,9901,0131,7821,623711,7681,1242,0472,2651,9142,1422,332-3,3993,0392,3551,3871,5872,791
Minority Interest in Earnings
14-20-15-83-21-16-21114136-7101-10-118
Net Income to Common
2,9432,943-3,9751,0211,7791,644871,7701,1132,0462,2611,9012,1362,334-3,4063,0292,3541,3971,5982,783
Net Income Growth
65.43%79.02%--42.32%59.84%-19.65%-96.15%-6.89%-47.89%-12.34%--37.24%-9.26%67.07%-8.84%5.89%43.58%30.56%-6.45%
Shares Outstanding (Basic)
1,2731,2701,2691,2661,2611,2591,2591,2561,2601,2881,2871,2831,2831,3101,3151,3131,3121,3221,3211,319
Shares Outstanding (Diluted)
1,2791,2771,2691,2701,2641,2611,2591,2591,2671,2931,2901,2871,2911,3191,3151,3211,3281,3361,3291,327
Shares Change (YoY)
1.19%1.27%0.79%0.87%-0.24%-2.48%-2.40%-2.18%-1.86%-1.97%-1.90%-2.57%-2.79%-1.27%-1.05%-0.45%0.45%1.44%1.06%0.99%
EPS (Basic)
2.312.32-3.130.811.411.310.071.410.881.591.761.481.661.78-2.592.311.790.991.212.11
EPS (Diluted)
2.302.30-3.130.801.411.300.071.410.881.581.751.481.651.77-2.592.291.770.981.202.10
EPS Growth
63.12%76.92%--43.26%60.23%-17.72%-96.00%-4.73%-46.67%-10.73%--35.37%-6.78%80.61%-9.05%5.36%30.67%29.03%-7.08%
Free Cash Flow
3,4002,606981,2903,8131,092-1,4152,4514,198-3,5472,1715,3176,454-2,6408,5435,0352,5123,4084,9135,361
Free Cash Flow Growth
-10.83%138.64%--47.37%-9.17%---53.90%-34.96%--74.59%5.60%156.93%-73.89%-6.08%21.76%19.41%266.64%-19.64%
Free Cash Flow Per Share
2.662.040.081.023.020.87-1.121.953.31-2.741.684.135.00-2.006.503.811.892.553.704.04
Dividends Per Share
0.6650.6650.6650.6650.6650.6650.6650.6650.6650.6050.6050.6050.6050.5500.5500.5500.5500.5000.5000.500
Dividend Growth
-----9.92%9.92%9.92%9.92%10.00%10.00%10.00%10.00%10.00%10.00%10.00%10.00%---
Gross Margin
15.56%12.84%13.42%13.74%15.22%13.20%13.16%14.67%14.20%14.79%15.13%15.30%15.68%16.53%16.50%17.18%17.43%17.92%17.21%18.17%
Operating Margin
4.66%2.00%-3.12%2.41%3.57%2.42%0.87%3.34%2.57%3.60%4.11%3.64%4.04%4.36%-4.83%5.79%4.61%3.06%4.15%5.96%
Profit Margin
2.94%2.77%-3.88%1.02%1.88%1.66%0.07%1.94%1.27%2.18%2.52%2.15%2.51%2.78%-4.19%3.77%3.07%1.81%2.15%3.84%
FCF Margin
3.39%2.47%0.10%1.30%4.03%1.12%-1.48%2.69%4.75%-3.78%2.42%5.98%7.57%-3.15%10.53%6.24%3.27%4.45%6.66%7.38%
EBITDA
5,7953,259-3,2072,3814,5283,5158323,0453,4094,5074,8174,3384,4474,702-3,9194,6694,5942,3463,0614,326
EBITDA Margin
5.77%3.08%-3.12%2.41%4.79%3.60%0.87%3.34%3.85%4.80%5.37%4.88%5.21%5.61%-4.83%5.79%5.98%3.06%4.15%5.96%
EBIT
4,6802,112-3,2072,3813,3742,3688323,0452,2713,3733,6903,2343,4463,659-3,9194,6693,5452,3463,0614,326
EBIT Margin
4.66%2.00%-3.12%2.41%3.57%2.42%0.87%3.34%2.57%3.60%4.11%3.64%4.04%4.36%-4.83%5.79%4.61%3.06%4.15%5.96%
Effective Tax Rate
24.91%-115.88%-14.59%38.49%31.91%23.66%32.38%24.35%28.86%24.33%24.98%25.53%25.60%25.97%23.51%26.40%21.53%17.78%26.01%25.27%
SEC Filings: 10-K · 10-Q